Lilly's second-quarter results reported Thursday were still more than fine: $15.5 billion in revenue beat Wall Street ...

Eli Lilly stock beats Q2 estimates with strong sales but faces competitive risks and high valuation. Here's why investors may ...

Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...

From the price of forthcoming weight loss pill orforglipron, to Most Favored Nation drug pricing and the market battle with ...

Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight in a late-stage ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...

Over the past year, a friend’s daughter — let’s call her Lily — has repeatedly called herself ugly. When Lily is supposed to ...

Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second quarter ...

While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...

The returning stars of “Freaky Friday” approach this long-gestating sequel with the kind of genuine verve and joy too often ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...